Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-17-055893

Director acquired 6,498 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Billings Paul Director 2017-09-02 Option exercise +6,498 6,498 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Billings Paul Director 2017-09-02 Option exercise · Restricted Stock Units −6,498 16,667 D: show line 2 in the form
Loading xslF345X03/a4.xml…